Evidence map›Paper›PMID 42796464›Full record

ArticleMolecules (Basel, Switzerland)2026

Chronic Chrysin, but Not Diazepam, Induces Anxiolytic-like Effects Without Behavioral Tolerance.

Luz María Nicio-Antonio, Gabriel Guillén-Ruiz, Ana Karen Limón-Vázquez, Jonathan Cueto-Escobedo, León Jesús Germán-Ponciano, Emma Virginia Herrera-Huerta, David Armando Argüello-Velasco, Juan Francisco Rodríguez-Landa

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luz María Nicio-AntonioPosgrado en Neuroetología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa-Enriquez 91190, Veracruz, Mexico.
Gabriel Guillén-RuizLaboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa-Enriquez 91190, Veracruz, Mexico.ORCID 0000-0003-4428-4706
Ana Karen Limón-VázquezLaboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa-Enriquez 91190, Veracruz, Mexico.ORCID 0000-0001-8827-410X
Jonathan Cueto-EscobedoDepartamento de Investigación Clínica y Traslacional, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa-Enriquez 91190, Veracruz, Mexico.ORCID 0000-0003-1465-012X
León Jesús Germán-PoncianoLaboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa-Enriquez 91190, Veracruz, Mexico.ORCID 0000-0001-9185-2900
Emma Virginia Herrera-HuertaFacultad de Ciencias Químicas, Universidad Veracruzana, Orizaba 94340, Veracruz, Mexico.ORCID 0000-0003-4045-1554
David Armando Argüello-VelascoPosgrado en Neuroetología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa-Enriquez 91190, Veracruz, Mexico.ORCID 0009-0001-6350-4148
Juan Francisco Rodríguez-LandaLaboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa-Enriquez 91190, Veracruz, Mexico.ORCID 0000-0001-5837-103X

Funding

Secretaría de Ciencia, Humanidades, Tecnología e Innovación Estímulo del Sistema Nacional de Investigadoras e Investigadores (CVU: GG-R: 285449; JFR-L: 121508)Secretaría de Ciencia, Humanidades, Tecnología e Innovación Proyecto 6943 (Investigadoras e Investigadores por México)Universidad Veracruzana SIREI project no. DGI: 266502025170
6 · The paper itself

Abstract

backgroundChrysin (5-7-dihydroxyflavone) exerts anxiolytic-like effects via the GABA

methodsThirty-five male Wistar rats were divided into five groups: vehicle, chrysin (1, 2.5, or 5 mg/kg), and diazepam (2 mg/kg, pharmacological control). Treatments were injected intraperitoneally for 32 days. On day 28, rats were evaluated in the elevated plus maze and locomotor activity tests. On day 32, all groups received a pharmacological challenge with 5 mg/kg diazepam and were assessed via sedative scale and the rota-rod test.

resultsChronic Chrysin (5 mg/kg) but not diazepam, maintained anxiolytic-like effects. No doses of chrysin showed pharmacological cross-tolerance to 5 mg/kg of diazepam, which produced incoordination and sedation, similar to vehicle.

conclusionsChronic treatment with chrysin (5 mg/kg) maintained their anxiolytic-like effects without pharmacological tolerance or cross-tolerance, unlike diazepam. This result supports the potential anxiolytic-like effects of chrysin in the long-term, as an alternative for anxiety disorders that require chronic treatment. This could contribute to the translational studies that could be applied to humans in the future.

Indexed as

Anti-Anxiety AgentsAnxietyBehavior, AnimalDiazepamFlavonoidsAnimalsDrug ToleranceMaleRatsRats, WistarReceptors, GABA-AAnti-Anxiety AgentschrysinDiazepamFlavonoidsReceptors, GABA-AanxiolyticchrysinGABAA receptorpharmacological tolerance

Identifiers

PMID42796464
PMCPMC13609220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.